MERCK & CO INC (NYSE: MRK)

Overview
current price
$144.71
$144.71
change
-2.82 | -1.91%
-2.82 | -1.91%
Yesterday's Close
147.53
open
147.94
volume
7.54 M
30d. avg volume.
10.27 M
1 day
144.10 - 148.00
52 weeks
77.58 - 156.92
p/e
118.02
beta
0.2150
market cap
363.98 B
dividend yield
2.30%
Industry
-
News and Commentary
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs The biotech sector has a new catalyst beyond GLP-1 drugs. Moderna Inc ...
Moderna Borrows $2 Billion To Expand Oncology Business Moderna, Inc. (MRNA
COVID-19 Made Moderna Famous: Cancer Could Define Its Future For years, Moderna, Inc's (
Moderna's Intismeran Close to Keytruda Style Oncology Opportunity: Analyst Moderna Inc. (MRNA
Moderna Reports Strong 5-Year Cancer Vaccine Data, Expands CEPI Partnership; Stock Falls Moderna, Inc. (MRNA
Federal Court Reportedly Halts Kennedy's Vaccine Panel, Putting COVID, Flu And RSV Shots At Risk A federal court order has halted the work of a key U.S. vaccine advisory panel, disrupting the system that guides COVID-19, flu and other immunization recommendations and raising...
US Cuts Childhood Vaccine Schedule To 11 Core Shots— What It Means For Vaccine Makers Like Merck And... In a move that could impact vaccine-makers like Merck & Co. Inc.
Market Update: Dow Rallies 560 Points to Record Close The Dow Jones Industrial Average soared to a new record closing high on Tuesday as market participants rotated out of technology names into stocks with lower valuations.
Merck, Doctors Reject Proposal To Break Up Combined MMR Vaccine A top U.S. health official's call to split the measles-mumps-rubella (MMR) vaccine into separate shots sparked strong pushback from Merck & Co., Inc.
UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even... Leading health insurers announced on Monday that they have agreed to a set of measures aimed at connecting patients to care faster and reducing paperwork for providers.
StockTwits
StockTwits

Join now and unlock premium features